UK signs deals for 114 million more doses of Moderna and Pfizer COVID-19 – .

0
9
UK signs deals for 114 million more doses of Moderna and Pfizer COVID-19 – .


LONDON, Dec. 1 (Reuters) – Britain on Wednesday announced agreements to purchase an additional 114 million Pfizer / BioNTech and Moderna COVID-19 vaccines, saying it had accelerated the signing of the new contracts in light of the emergence of the new Omicron a variant.

The deal involves 60 million additional Moderna vaccines (MRNA.O) and 54 million Pfizer doses (PFE.N) for next year and 2023, and will also include access to all modified vaccines if needed to control the Omicron strain or any other vaccine. another variant, said the British Department of Health.

“These new agreements will help sustain the greater UK immunization effort – which has so far provided over 115 million first, second and recall across the UK – and ensure that we can protect even more people in the years to come, ”said Health Minister Sajid. said Javid.

Register now for FREE and unlimited access to reuters.com

So far, nearly 51 million people in Britain have received their first COVID vaccine – nearly 89% of the population over the age of 12, over 46 million have received two doses and some 18.6 million have received a reminder.

On Tuesday, Prime Minister Boris Johnson announced a new target this week of offering all adults a vaccine booster by the end of January, which means accelerating the rollout of one million more doses per week. Read more

So far, 32 cases of the highly mutated Omicron variant, which are feared no longer transmissible, have been identified in Britain, prompting the government to speed up the vaccination program.

Britain has made masks on public transport and shops mandatory, but Johnson and his ministers hope the recall program will mean there will be no need for restrictions or additional measures to curb gatherings social.

The contracts for the additional vaccines come on top of an order for 35 million Pfizer doses placed in August for the second half of next year, and 60 million Novavax doses and 7.5 million GlaxoSmithKline (GSK) doses / Sanofi which are due in 2022 but are yet to be approved by the UK regulator.

Rich countries have been accused of not doing enough to distribute stocks of vaccines to poorer countries, and the UK government has said it remains committed to donating 100 million doses by mid-2022, claiming that $ 30 million would be donated by the end of this year.

Johnson will also host a panel discussion on Thursday of executives from major pharmaceutical companies, including AstraZeneca, GSK and Pfizer, to discuss preparations to deal with any future pandemic.

Register now for FREE and unlimited access to reuters.com

Register

Reporting by Michael Holden; edited by David Evans

Our Standards: Thomson Reuters Trust Principles.

LEAVE A REPLY

Please enter your comment!
Please enter your name here